3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
12
Breast Neoplasms
8
Vitamin D Deficiency
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
3
Leukemia
3
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Male Urogenital Diseases
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Warts
1
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Osteoporosis
1
Obesity
1
Neurofibromatosis 1
1
Neuralgia
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
AZD 6244
9
trametinib
3
mirdametinib
3
Lovastatin
3
Sirolimus
2
Inhalation
2
Everolimus
2
Acetylcysteine
2
tipifarnib
1
thymoglobulin
1
pirfenidone
1
peginterferon alfa-2b
1
omipalisib
1
fludarabine
1
cediranib
1
binimetinib
1
Vitamin D
1
Vincristine
1
Vinblastine
1
Temozolomide
1
Sunitinib
1
Saline Solution
1
Rituximab
1
Radiotherapy
1
Radiation
1
Photochemotherapy
1
N-monoacetylcystine
1
Methotrexate
1
Melphalan
1
Levetiracetam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neurofibromatosis 1
×
Cholecalciferol
×
Clear all
NCT01968590
2022-05-25
VitDBoneNF1
University of Utah
Phase 2
Terminated
26 enrolled